ICU Medical, Inc. (ICUI) Balance Sheet
ICUI balance sheet, 2025
December 31, 2025 · U.S. dollars$4.05B assets = $1.93B liabilities + $2.12B equity
Both columns are drawn to the same scale: what ICUI owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ICUI financial health
Descriptive bands, not a rating. Fiscal 2025.
ICUI balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $704.7M2016 | $4.05B2025 | +21.4%/yr | |
| Total liabilities | $44.5M2016 | $1.93B2025 | +52.0%/yr | |
| Shareholders’ equity | $660.2M2016 | $2.12B2025 | +13.9%/yr | |
| Cash & short-term investments | $445.1M2016 | $308.0M2025 | −4.0%/yr | |
| Total debt | $9.1M2017 | $1.39B2025 | +87.6%/yr | |
| Net cash (debt) | $291.1M2017 | −$1.08B2025 | −$1.4B | |
| Working capital | $528.6M2016 | $678.6M2025 | +$150.0M | |
| Book value per share | $38.262016 | $85.282025 | +9.3%/yr | |
| Current ratio | 14.042016 | 2.362025 | −11.68 | |
| Debt / equity | 0.012017 | 0.662025 | +0.65 | |
| Shares outstanding | 17.3M2016 | 24.9M2025 | +4.2%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ICUI assets
ICUI liabilities and equity
ICUI debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ICUI balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $308.0M | $308.6M | $254.7M | $213.0M | $567.2M | $410.8M | $292.6M | $382.1M | $300.1M | $445.1M |
| Cash & equivalents | $308.0M | $308.6M | $254.2M | $208.8M | $552.8M | $396.1M | $268.7M | $344.8M | $290.1M | $445.1M |
| Short-term investments | — | $1.2M | $501,000 | $4.2M | $14.4M | $14.7M | $24.0M | $37.3M | $10.1M | $445.1M |
| Receivables | $180.5M | $202.7M | $182.1M | $246.9M | $124.8M | $127.8M | $202.2M | $196.4M | $149.1M | $59.1M |
| Inventory | $615.9M | $584.7M | $709.4M | $696.0M | $290.2M | $314.9M | $337.6M | $311.2M | $288.7M | $49.3M |
| Other current assets | $73.1M | $346.0M | $75.0M | $79.3M | $47.5M | $60.9M | $49.7M | $37.3M | $126.8M | $15.6M |
| Total current assets | $1.18B | $1.44B | $1.22B | $1.24B | $1.03B | $914.4M | $882.2M | $927.0M | $864.7M | $569.1M |
| Property, plant & equipment (net) | $506.3M | $499.3M | $685.5M | $713.6M | $510.9M | $513.2M | $490.6M | $432.6M | $398.7M | $85.7M |
| Goodwill & intangible assets | $2.13B | $2.17B | $2.34B | $2.43B | $231.8M | $230.2M | $242.7M | $144.6M | $156.1M | $28.0M |
| Long-term investments | $131.6M | $3.0M | $3.1M | $3.7M | $4.6M | $13.0M | $0 | $2.0M | $14.6M | $0 |
| Other non-current assets | $101.9M | $86.0M | $125.5M | $131.2M | $103.7M | $92.9M | $77.0M | $79.1M | $62.9M | $21.9M |
| Total assets | $4.05B | $4.20B | $4.38B | $4.52B | $1.88B | $1.76B | $1.69B | $1.59B | $1.50B | $704.7M |
| Liabilities | ||||||||||
| Accounts payable | $154.4M | $148.0M | $150.0M | $215.9M | $81.1M | $71.9M | $128.6M | $120.5M | $78.2M | $14.6M |
| Short-term debt | $34.7M | $66.7M | $71.2M | $47.9M | $9.0M | $9.3M | $7.4M | $6.2M | $9.1M | — |
| Deferred revenue | $33.8M | $30.4M | $31.6M | $30.8M | $12.6M | $5.6M | $6.7M | $3.8M | $3.3M | — |
| Total current liabilities | $498.9M | $556.2M | $481.8M | $494.6M | $200.8M | $195.5M | $248.5M | $249.3M | $210.3M | $40.5M |
| Long-term debt | $1.27B | $1.53B | $1.58B | $1.62B | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $47.7M | $58.8M | $75.1M | $80.9M | $45.0M | $52.1M | $36.3M | — | — | — |
| Other long-term liabilities | $161.9M | $150.7M | $195.4M | $307.5M | $63.9M | $65.9M | $66.7M | $72.4M | $88.4M | $4.0M |
| Total liabilities | $1.93B | $2.24B | $2.26B | $2.43B | $264.7M | $261.4M | $315.1M | $321.7M | $298.7M | $44.5M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $2.5M | $2.5M | $2.4M | $2.4M | $2.1M | $2.1M | $2.1M | $2.0M | $2.0M | $1.6M |
| Retained earnings (deficit) | $690.9M | $690.2M | $807.8M | $837.5M | $911.8M | $808.7M | $721.8M | $620.7M | $585.6M | $517.0M |
| Treasury stock | — | — | — | — | −$27,000 | −$39,000 | −$157,000 | −$95,000 | $0 | −$14,000 |
| Accumulated other comprehensive income | −$34.6M | −$139.4M | −$53.1M | −$81.0M | −$19.3M | −$1.5M | −$15.4M | −$16.9M | −$15.0M | −$21.3M |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $2.12B | $1.97B | $2.12B | $2.09B | $1.62B | $1.50B | $1.38B | $1.26B | $1.20B | $660.2M |
| Key figures | ||||||||||
| Total debt | $1.39B | $1.64B | $1.70B | $1.73B | $45.0M | $52.7M | $36.3M | $6.2M | $9.1M | — |
| Net cash (debt) | −$1.08B | −$1.33B | −$1.45B | −$1.52B | $522.2M | $358.1M | $256.4M | $376.0M | $291.1M | — |
| Working capital | $678.6M | $885.8M | $739.4M | $740.6M | $829.0M | $718.9M | $633.7M | $677.7M | $654.4M | $528.6M |
| Tangible book value | −$9.5M | −$208.3M | −$219.6M | −$342.1M | $1.38B | $1.27B | $1.13B | $1.12B | $1.04B | $632.2M |
| Book value per share | $85.28 | $80.58 | $88.14 | $87.56 | $74.19 | $69.58 | $63.92 | $58.50 | $57.45 | $38.26 |
| Shares outstanding | 24.9M | 24.4M | 24.1M | 23.9M | 21.8M | 21.6M | 21.5M | 21.6M | 20.9M | 17.3M |
| Current ratio | 2.36 | 2.59 | 2.53 | 2.50 | 5.13 | 4.68 | 3.55 | 3.72 | 4.11 | 14.04 |
| Quick ratio | 0.98 | 0.92 | 0.91 | 0.93 | 3.45 | 2.75 | 1.99 | 2.32 | 2.14 | 12.44 |
| Debt / equity | 0.66 | 0.84 | 0.80 | 0.83 | 0.03 | 0.04 | 0.03 | 0.00 | 0.01 | — |
| Equity / assets | 52.4% | 46.7% | 48.5% | 46.3% | 85.9% | 85.2% | 81.4% | 79.7% | 80.0% | 93.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $298.3M | $288.3M | $308.0M | $299.7M | $300.0M | $289.7M | $308.6M | $312.5M | $302.6M | $251.4M | $254.7M | $199.0M |
| Cash & equivalents | $298.3M | $288.3M | $308.0M | $299.7M | $300.0M | $289.7M | $308.6M | $312.5M | $302.6M | $251.4M | $254.2M | $197.2M |
| Short-term investments | — | — | — | — | — | — | $0 | $1.4M | $1.2M | $1.2M | $501,000 | $1.8M |
| Receivables | $218.6M | $201.1M | $180.5M | $217.2M | $219.2M | $204.7M | $202.7M | $198.8M | $154.9M | $169.0M | $182.1M | $164.2M |
| Inventory | $607.4M | $605.6M | $615.9M | $622.4M | $616.5M | $590.3M | $584.7M | $692.0M | $682.9M | $693.0M | $709.4M | $759.6M |
| Other current assets | $86.6M | $94.0M | $73.1M | $67.9M | $44.4M | $339.2M | $346.0M | $54.7M | $95.5M | $74.3M | $73.4M | $90.9M |
| Total current assets | $1.21B | $1.19B | $1.18B | $1.21B | $1.18B | $1.42B | $1.44B | $1.26B | $1.24B | $1.19B | $1.22B | $1.21B |
| Property, plant & equipment (net) | $485.4M | $502.1M | $506.3M | $512.6M | $511.3M | $503.3M | $499.3M | $658.5M | $663.8M | $670.1M | $682.8M | $682.5M |
| Goodwill & intangible assets | $2.05B | $2.08B | $2.13B | $2.16B | $2.20B | $2.17B | $2.17B | $2.26B | $2.26B | $2.30B | $2.34B | $2.34B |
| Long-term investments | $133.9M | $130.9M | $131.6M | $134.1M | $131.6M | $3.0M | $3.0M | $3.1M | $3.1M | $3.1M | $3.1M | $3.1M |
| Other non-current assets | $89.0M | $107.2M | $101.9M | $85.4M | $84.4M | $82.5M | $86.0M | $121.3M | $127.1M | $131.2M | $129.9M | $141.7M |
| Total assets | $3.97B | $4.01B | $4.05B | $4.10B | $4.11B | $4.18B | $4.20B | $4.31B | $4.29B | $4.29B | $4.38B | $4.38B |
| Liabilities | ||||||||||||
| Accounts payable | $149.2M | $174.0M | $154.4M | $171.8M | $168.8M | $180.4M | $148.0M | $168.6M | $155.5M | $152.5M | $150.0M | $149.3M |
| Short-term debt | $18.8M | $34.2M | $34.7M | $15.6M | $29.5M | $61.3M | $66.7M | $68.1M | $69.9M | $69.5M | $72.0M | $66.4M |
| Deferred revenue | $54.4M | $60.7M | $33.8M | $28.9M | $21.9M | $32.5M | $30.4M | $26.9M | $33.8M | $32.8M | $31.6M | $28.8M |
| Total current liabilities | $498.4M | $517.9M | $498.9M | $492.9M | $482.8M | $549.0M | $556.2M | $549.6M | $511.9M | $455.4M | $481.8M | $464.0M |
| Long-term debt | $1.21B | $1.26B | $1.27B | $1.31B | $1.34B | $1.49B | $1.53B | $1.54B | $1.55B | $1.57B | $1.58B | $1.59B |
| Lease obligations | $40.4M | $45.2M | $47.7M | $50.6M | $52.5M | $64.0M | $58.8M | $64.7M | $72.5M | $69.9M | $75.1M | $79.1M |
| Other long-term liabilities | $108.6M | $122.1M | $161.9M | $168.8M | $171.1M | $159.3M | $150.7M | $163.6M | $182.1M | $198.9M | $195.4M | $225.2M |
| Total liabilities | $1.82B | $1.90B | $1.93B | $1.98B | $1.99B | $2.20B | $2.24B | $2.26B | $2.25B | $2.22B | $2.26B | $2.28B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $2.5M | $2.5M | $2.5M | $2.5M | $2.5M | $2.5M | $2.5M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M |
| Retained earnings (deficit) | $740.1M | $721.0M | $690.9M | $706.6M | $710.0M | $674.7M | $690.2M | $714.0M | $747.0M | $768.4M | $807.8M | $825.0M |
| Accumulated other comprehensive income | −$43.3M | −$51.9M | −$34.6M | −$33.0M | −$32.6M | −$105.4M | −$139.4M | −$62.4M | −$91.8M | −$69.5M | −$53.1M | −$84.7M |
| Total shareholders' equity | $2.15B | $2.11B | $2.12B | $2.13B | $2.12B | $1.99B | $1.97B | $2.05B | $2.04B | $2.07B | $2.12B | $2.10B |
| Key figures | ||||||||||||
| Total debt | $1.27B | $1.34B | $1.39B | $1.36B | $1.39B | $1.60B | $1.64B | $1.66B | $1.68B | $1.69B | $1.70B | $1.71B |
| Net cash (debt) | −$973.3M | −$1.05B | −$1.08B | −$1.06B | −$1.09B | −$1.31B | −$1.33B | −$1.35B | −$1.38B | −$1.44B | −$1.45B | −$1.52B |
| Working capital | $712.5M | $671.1M | $678.6M | $714.4M | $697.3M | $874.9M | $885.8M | $708.5M | $724.1M | $732.4M | $737.8M | $749.7M |
| Tangible book value | $99.8M | $27.4M | −$9.5M | −$36.3M | −$84.2M | −$184.1M | −$208.3M | −$215.5M | −$218.9M | −$228.4M | −$219.6M | −$237.4M |
| Book value per share | $85.92 | $83.87 | $86.03 | $86.17 | $85.63 | $81.00 | $80.24 | $83.83 | $83.54 | $85.37 | $87.96 | $86.11 |
| Shares outstanding | 25.0M | 25.2M | 24.7M | 24.7M | 24.7M | 24.5M | 24.5M | 24.4M | 24.4M | 24.2M | 24.1M | 24.4M |
| Current ratio | 2.43 | 2.30 | 2.36 | 2.45 | 2.44 | 2.59 | 2.59 | 2.29 | 2.41 | 2.61 | 2.53 | 2.62 |
| Quick ratio | 1.04 | 0.94 | 0.98 | 1.05 | 1.08 | 0.90 | 0.92 | 0.93 | 0.89 | 0.92 | 0.91 | 0.78 |
| Debt / equity | 0.59 | 0.64 | 0.66 | 0.64 | 0.66 | 0.81 | 0.84 | 0.81 | 0.82 | 0.82 | 0.80 | 0.82 |
| Equity / assets | 54.2% | 52.6% | 52.4% | 51.8% | 51.5% | 47.5% | 46.7% | 47.6% | 47.5% | 48.2% | 48.5% | 47.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 19, 2026); data from EODHD.
ICUI financial position
At the end of fiscal 2025 (December 31, 2025), ICU Medical had total assets of $4.1 billion (down 3.6% from a year earlier), total liabilities of $1.9 billion and shareholders' equity of $2.1 billion. It held $308.0 million in cash and short-term investments against $1.4 billion of debt, net debt of $1.1 billion. Its current ratio was 2.36. In the latest quarter (ended June 30, 2026) total assets were $4.0 billion and equity $2.2 billion.
Related: ICUI income statement, ICUI cash flow statement, ICUI key metrics. See the ICUI stock overview for the latest quote and news.
ICUI balance sheet FAQ
What are ICU Medical's total assets?
ICU Medical reported total assets of $4.1 billion at the end of fiscal 2025 (December 31, 2025), compared with $4.2 billion a year earlier.
How much debt does ICU Medical have?
ICU Medical had $1.4 billion of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.66.
How much cash does ICU Medical have?
ICU Medical held $308.0 million in cash and short-term investments at the end of fiscal 2025; with $1.4 billion of debt that is net debt of $1.1 billion.
What is ICU Medical's book value?
ICU Medical's shareholders' equity (book value) was $2.1 billion at the end of fiscal 2025, or $85.28 per share.
What is ICU Medical's current ratio?
ICU Medical had current assets of $1.2 billion and current liabilities of $498.9 million, a current ratio of 2.36 (it can cover its short-term obligations).
How much goodwill does ICU Medical have?
ICU Medical carried $2.1 billion of goodwill and intangible assets, 52.7% of total assets, at the end of fiscal 2025.